UK markets open in 1 hour 27 minutes
NIKKEI 225
38,019.16 +390.68 (+1.04%) HANG SENG
17,670.06 +385.52 (+2.23%) CRUDE OIL
83.94 +0.37 (+0.44%) GOLD FUTURES
2,348.40 +5.90 (+0.25%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,350.46 +98.20 (+0.19%)
Acutus Medical, Inc. (AFIB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.86M |
| Enterprise value | 20.93M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.66 |
| Price/book (mrq) | 0.53 |
| Enterprise value/revenue | 2.92 |
| Enterprise value/EBITDA | -3.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.20 |
| 52-week change 3 | -81.58% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 1.0900 |
| 52-week low 3 | 0.1600 |
| 50-day moving average 3 | 0.1882 |
| 200-day moving average 3 | 0.3777 |
Share statistics
| Avg vol (3-month) 3 | 1.07M |
| Avg vol (10-day) 3 | 245.98k |
| Shares outstanding 5 | 29.72M |
| Implied shares outstanding 6 | 30.33M |
| Float 8 | 23.42M |
| % held by insiders 1 | 3.60% |
| % held by institutions 1 | 23.50% |
| Shares short (15 Apr 2024) 4 | 553.6k |
| Short ratio (15 Apr 2024) 4 | 0.68 |
| Short % of float (15 Apr 2024) 4 | 1.90% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.86% |
| Shares short (prior month 15 Mar 2024) 4 | 984.7k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -288.73% |
Management effectiveness
| Return on assets (ttm) | -13.80% |
| Return on equity (ttm) | -32.16% |
Income statement
| Revenue (ttm) | 7.16M |
| Revenue per share (ttm) | 0.25 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -20.49M |
| Net income avi to common (ttm) | -11.92M |
| Diluted EPS (ttm) | -0.4100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 22.4M |
| Total cash per share (mrq) | 0.75 |
| Total debt (mrq) | 38.48M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.44 |
| Book value per share (mrq) | -0.03 |
Cash flow statement
| Operating cash flow (ttm) | -63.12M |
| Levered free cash flow (ttm) | 8.17M |
© 2024 Yahoo. All rights reserved.